In the latest Cardiac Wire, we discuss… 🫀@MedAxiom Report: Cardiologist Compensation Soars, Patient Access Struggles 🫀Ketone Bodies as AFib Biomarker 🫀@Medtronic Endurant Label Change And more cardiology news: https://t.co/84TXYtvEXu

A recent study out of the U.K. suggests that multidisciplinary team management could significantly reduce death or rehospitalization risk for HF patients across the LVEF spectrum. https://t.co/bY28DZwJw9

A recent JACC analysis of the Epic Cosmos database suggests lipoprotein(a) screening is still one of cardiology’s most neglected risk assessment tools, representing a serious gap in the way we evaluate patients’ CVD risk. https://t.co/iQvUpiBVko

@DutchRojas @joinBunkerhill @AstraZeneca @CaristoHeart @Amgen @3drlabs @MattRamsisMD

In the latest Cardiac Wire, we discuss… 🫀Screening For Lp(a) is Still Too Uncommon 🫀@viz_ai Adds Viz ACS to Cardio Suite 🫀LAAC Might Not Help Secondary IS And more cardiology news: https://t.co/Z18Q2cqLOb

Secondary cardiomyopathies might not be caused by environmental factors after all, after a massive four-biobank study found that their development is a lot more dependent on which combination of genetic risks you already have. https://t.co/XV0fD8qFQY

@drjohnm @DimitriMaamari @OsaeedMD @LaurentBertole1 @kardiologykazi

In the latest Cardiac Wire, we discuss… 🫀Secondary Cardiomyopathy Isn’t so Secondary After All 🫀AI for Body Composition Analysis 🫀@Rad_Partners Launches 2-for-1 Screening Tool And more cardiology news: https://t.co/Bk1Py5LFoc

Cardiac Wire attended its first ever @HFSA meeting this year, exploring everything from the latest pharmaceutical advancements to the complex relationship between cardio-renal health and beyond. Here are some of the big takeaways from HFSA 2025. https://t.co/SamEUX9ojW

@us2_ai @Intelerad @MasriAhmadMD

In the latest Cardiac Wire, we discuss… 🫀Where HF is Headed – Takeaways from @HFSA 2025 🫀@Eko_Health EFAST’s FDA Clearance 🫀Echo AI Classifies Aortic Stenosis And more cardiology news: https://t.co/mkTldlZWHu

The latest Global Burden of Disease study revealed that cardiovascular disease is a bigger part of the global health battle than previously thought, underscoring the impact of CVD on population-level health despite medical advances. https://t.co/5IyuHjaPZu

@AxonTherapies @Philips @luisnombela @hardikdesai198 @munes_fares @CaristoHeart

In the latest Cardiac Wire, we discuss… 🫀CVD: A Bigger Global Health Problem Than We Realize 🫀Abbott’s Coming IVL System 🫀FDA Cracks Down on Drug Ads And more cardiology news: https://t.co/EALhgYSPMM

@Heartflow @MichaelAlbertMD @joinBunkerhill @FlyteHealth @Cleerlyhealth

In the latest Cardiac Wire, we discuss… 🫀Meds-to-Beds Improve PCSK9 Inhibitor Access and Efficacy 🫀A New STEMI Intervention 🫀@Heartflow Gets New Plaque Analysis 510(k) And more cardiology news: https://t.co/rjEzpVPPkZ

Young heart attack patients might actually be a completely different disease population than previously understood, after the OCTOPUS registry analysis revealed that the causes of early MI and the people who get them aren’t what’s expected.

@Novartis @AmerMedicalAssn @ThryvTrx @EliLillyandCo @yadersandoval

In the latest Cardiac Wire, we discuss… 🫀OCTOPUS: What Really Causes MI in Younger Patients 🫀AMA Releases CPT 2026 Code Set 🫀Medicare’s AI Rejections And more cardiology news!

Cardiovascular risk communication might be failing patients when they need it most, after the HARIPA study revealed significant disconnects between patient and physician perceptions of future cardiovascular risk and procedural complications.